Agios Pharmaceuticals Inc...

NASDAQ: AGIO · Real-Time Price · USD
37.00
0.32 (0.87%)
At close: Aug 15, 2025, 3:59 PM
37.10
0.27%
After-hours: Aug 15, 2025, 06:01 PM EDT

Agios Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-112.02M -89.29M -96.52M 947.91M -96.12M -81.55M -95.94M -91.32M -83.81M -81.02M 36.53M -81.75M -91.81M -94.77M -98.58M -84.26M -82.79M -90.88M
Depreciation & Amortization
1.26M 1.28M 1.37M 1.34M 1.59M 1.35M 1.4M 1.62M 1.81M 1.79M 1.81M 1.98M 2.29M 2.48M 2.2M 2.21M 2.35M 2.48M
Stock-Based Compensation
14.69M 11.36M 10.9M 11.14M 11.56M 9.23M 13.81M 9.08M 11.74M 10.14M 11.46M 11.16M 11.16M 15.51M 11.62M 12.15M 14.88M 14.85M
Other Working Capital
n/a -32.46M -43.33M 13.62M 12.46M -25.78M 12.57M -3.81M 5.63M 12.25M 6.96M -5.89M 8.77M -16.5M -4.46M -11.46M -4.94M -17.82M
Other Non-Cash Items
18.95M -34.84M -2.65M -1.06B 17.34M 15.22M 26.22M 20.2M 2.65M -318K -127.29M 1.87M 2.48M 3.59M 2.41M 2.37M 2.34M 2.42M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -23.59M 1.48M -2.96M n/a n/a n/a n/a n/a -2.48M -8.42M -46.52M -28.86M
Change in Working Capital
n/a n/a -46.26M 18.86M 10.13M -28.98M 5.6M -2.7M 3.82M -25.78M 11.32M -4.61M 1.4M -24.54M 736K -9.23M -7.56M -20.76M
Operating Cash Flow
-77.12M -111.49M -133.17M -84.22M -72.59M -99.87M -72.49M -61.64M -66.75M -95.18M -66.16M -71.35M -74.23M -97.73M -84.09M -85.18M -117.29M -120.75M
Capital Expenditures
-875K -766K -967K -419K -158K -141K -234K -17.87M 3K -399K -113K -38K -1.93M -2.8M -4.5M 22K -249K -1.01M
Cash Acquisitions
n/a n/a n/a -40K n/a 40K n/a 17.5M -47.12M 150K 132.75M -104.11M n/a n/a n/a n/a n/a n/a
Purchase of Investments
-130.8M -174.9M -198.33M -995.5M -104.55M -244.06M -90.44M -95M -104.14M -128.35M -248.56M -174.47M -251.83M -355.92M -426.81M -452.51M -437.03M -61.86M
Sales Maturities Of Investments
220.64M 288.26M 150.13M 157.58M 141.95M 368.72M 186.19M 151.04M 151.26M 186.2M 198.88M 278.58M 336.57M 332.15M 336.89M 219.76M 139.13M 134.02M
Other Investing Acitivies
-10M n/a n/a 1.09B 37.4M 40K 95.75M -16.32M 47.12M 57.99M n/a 104.11M 84.74M -23.77M -89.92M -232.75M -297.9M 1.8B
Investing Cash Flow
78.97M 112.59M -49.16M 250.79M 37.24M 124.56M 95.51M 39.34M 47.13M 57.6M 82.95M 104.07M 82.81M -26.57M -94.42M -232.73M -298.15M 1.87B
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -83K -84K -83K -81K 195K -603K -84K -86K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -19.05M -254.39M -529.05M n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
65K 1.62M 4.84M 2.64M 1.1M 5.86M 847K 1.88M 237K 2.47M 105K 1.27M 16K 1.29M 267K 4.01M -503.37M 7.35M
Financial Cash Flow
65K 1.62M 4.84M 2.64M 1.1M 5.86M 847K 1.88M 237K 2.47M 22K 1.19M -67K 1.21M -18.59M -250.99M -503.46M 7.26M
Net Cash Flow
1.91M 2.72M -177.48M 169.21M -34.25M 30.56M 23.87M -20.42M -19.39M -35.12M 16.81M 33.91M 8.52M -123.1M -197.1M -568.9M -918.9M 1.76B
Free Cash Flow
-78M -112.25M -134.13M -84.64M -72.75M -100.01M -72.72M -79.51M -66.75M -95.58M -66.28M -71.39M -76.16M -100.54M -88.59M -85.16M -117.54M -121.76M